Corneal Transplantation Guided by OCT RESCAN

April 8, 2016 updated by: Walton Nose, Federal University of São Paulo

Corneal Transplantation Guided by OCT RESCAN: Pre-op, Intra-op and Post-op Evaluation

The investigators will evaluate 30 patients with surgical indication for corneal transplantation. Participants will be divided according to the following diseases diseases: keratoconus, bullous keratopathy, corneal dystrophies. Participants will be informed about the risks and benefits of the study and sign an informed consent form. In the preoperative evaluation will be submitted to a complete ophthalmologic examination with complementary tests, such as optical coherence tomography.

One group of participants will undergo corneal surgery using the OCT Lumera microscope RESCAN - ZEISS and another group with a conventional microscope. Everyone will have their filmed and documented surgery. The team of surgeons will answer the questionnaire on the surgical difficulty about the ease of assessing corneal transplantation. After surgery, participants will be assessed on days 1, 7,15, 30, 60, 90 and 180 after surgery.

Surgeries and study procedures will be performed by the same team of surgeons and performed by IPEPO - Paulista Institute of Studies and Research in Ophthalmology / Vision Institute.

Study Overview

Detailed Description

Participants will be allocated in one of the following groups:

  1. Control Group The control group will undergo corneal transplant with conventional microscope without coupled OCT. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation (ANNEX 1).
  2. Group OCT RESCAN In the group microscope coupled to OCT, patients will undergo retinal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation (ANNEX 1).

The investigators will evaluate intraoperative conditions, complications, operative time and postoperative results in both groups.

All patients will be monitored and evaluated with full ophthalmological examination in all postoperative visits (day 1, 7,15,30, 60, 90, 180) and will be subjected to the following tests:

  • Measurement of visual acuity with best correction
  • Previous Biomicroscopy
  • Corneal Topography
  • tonometry
  • Optical coherence tomography (OCT)
  • Microscopy speculate

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Visual acuity less than 20/60 in the affected eye
  • 18 years at least
  • Diagnostic of the following diseases:

    • keratoconus
    • Keratopathy Bullosa
    • Corneal dystrophy

Exclusion Criteria:

  • Better visual acuity than or equal to 20/60

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lumera Microscope with OCT RESCAN
In the group microscope coupled to OCT, patients will undergo corneal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation
corneal transplantation guided by Lumera Microscope with OCT RESCAN
Active Comparator: Conventional Microscope
The control group will undergo corneal transplant with conventional microscope without coupled OCT. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation
corneal transplantation guided by Conventional Microscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess optimal maneuvers in corneal transplantation (separation layers)
Time Frame: Day 0
assessed by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty)
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare the time of surgery between groups
Time Frame: Day 0
by a questionnaire responded by surgeons (until 30 minutes, between 30-60 minutes, more than 60 minutes)
Day 0
To describe the surgical difficulty for corneal transplantation
Time Frame: Day 0
by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty)
Day 0
Change of Day 1 Ocular inflammation at 1 month (Day 30)
Time Frame: from Day1 to Day30
ocular inflammation scored as mild, moderate or severe
from Day1 to Day30
Change from Baseline Intraocular Pressure at 6 months (Day180)
Time Frame: from Baseline to Day 180
intraocular pressure assessed by goldmann tonometer
from Baseline to Day 180
Change from Baseline Visual Acuity at 6 months (Day 180)
Time Frame: from Baseline to Day 180
visual acuity tested by ETDRS chart
from Baseline to Day 180

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Walton Nose, MD, PhD, Federal University of São Paulo UNIFESP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (Anticipated)

December 1, 2016

Study Completion (Anticipated)

March 1, 2017

Study Registration Dates

First Submitted

March 22, 2016

First Submitted That Met QC Criteria

April 8, 2016

First Posted (Estimate)

April 13, 2016

Study Record Updates

Last Update Posted (Estimate)

April 13, 2016

Last Update Submitted That Met QC Criteria

April 8, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

scientific publication

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Keratoconus

Clinical Trials on Lumera Microscope with OCT RESCAN

3
Subscribe